Memorial Şişli Hospital
Memorial Şişli Hospital
Turquie, Istanbul
Betul Tavil
29 années d'expérience
accréditations :
La clinique est certifiée :
En Turquie, le traitement de la cirrhose par cellules souches coûte de $12,000 à $21,000. Le tarif final dépend de la source des cellules, du nombre total et de l'accréditation internationale de l'établissement. En France, ces interventions coûtent environ $35,000. Les patients choisissant la Turquie économisent environ 53%. La plupart des programmes incluent les bilans médicaux, l'intervention et les transferts VIP entre l'aéroport et l'hôpital.
Avis d'expert Bookimed : Privilégier un centre pluridisciplinaire offre le meilleur rapport qualité-prix pour les cas hépatiques complexes. Le Medical Park Antalya, avec des spécialistes comme le Dr Aziz Kemal Emek, propose une prise en charge intégrée. Le Memorial Şişli, premier hôpital turc accrédité JCI, affiche un taux de succès de 90 % en transplantation. Cet environnement assure que les protocoles cellulaires respectent les mêmes normes de sécurité rigoureuses que les chirurgies lourdes.
| Turquie | Espagne | Allemagne | |
| Traitement de la cirrhose du foie par cellules souches | de $12,000 | de $20,000 | de $30,000 |
Bookimed ne facture pas de frais supplémentaires pour les prix des Traitement de la cirrhose du foie par cellules souches. Les tarifs sont issus des listes de prix officielles des cliniques. Vous payez directement à la clinique lors de votre arrivée pour votre Traitement de la cirrhose du foie par cellules souches.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans Traitement de la cirrhose du foie par cellules souches et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de Traitement de la cirrhose du foie par cellules souches.
Le professeur associé Akin est spécialisé dans le traitement de la cirrhose du foie dans le meilleur hôpital d'Antalya, apportant plus d'une décennie d'expertise en gastro-entérologie.
Le Prof. Emek est spécialisé dans les traitements hépatiques au complexe hospitalier Medical Park Antalya, avec une solide formation universitaire en chirurgie.
Spécialisé dans les maladies du foie et le traitement de la cirrhose, avec une vaste expérience en gastroentérologie acquise dans les meilleurs hôpitaux turcs.
Spécialisé en gastro-entérologie avec un accent sur les maladies du foie, le Dr Seymur Aslanov apporte une expertise approfondie dans les traitements par cellules souches pour la cirrhose hépatique.
Stem cell therapy for liver cirrhosis is legal and strictly regulated in Turkey. The Turkish Ministry of Health provides oversight by granting case-by-case approvals. Authorized clinics must use cGMP-certified laboratories and follow mandatory protocols for cell sourcing and patient follow-up. While legal, it remains an experimental treatment.
Bookimed Expert Insight: While many clinics offer these treatments, the most reliable outcomes are found at hospitals with strong transplant backgrounds. Memorial Şişli Hospital, for instance, maintains a 90% organ transplant success rate. This high-level surgical infrastructure ensures safer administration of regenerative therapies compared to smaller standalone clinics.
Patient Consensus: Patients often report temporary improvements in liver function scores like MELD. Most recommend verifying Ministry of Health accreditation and consulting a home-country hepatologist beforehand.
Leading specialists for stem cell treatment of liver cirrhosis in Turkey include Professor Aziz Kemal Emek and Associate Professor Mete Akin at Medical Park Antalya. These experts utilize mesenchymal stem cells within JCI-accredited facilities to stimulate hepatic regeneration and improve liver function markers for patients with chronic liver disease.
Bookimed Expert Insight: While many clinics market regenerative medicine, the most reliable outcomes for liver cirrhosis are found in university-affiliated hospitals like İstinye University Liv Hospital or Medical Park. These institutions integrate stem cell therapy with traditional hepatology departments, ensuring patients are monitored by transplant-certified teams rather than standalone private wellness clinics.
Patient Consensus: Patients emphasize the importance of verifying a specialist's PubMed publications and suggest prioritizing centers affiliated with major universities. Many advise getting a second opinion from a transplant surgeon before committing to stem cell protocols for advanced cirrhosis.
Stem cell therapy currently cannot replace a liver transplant for end-stage organ failure. Evidence shows it functions as a complementary bridge therapy to stabilize patients awaiting donors or to slow fibrosis in early-stage disease. Full organ replacement remains experimental through lab-grown organoids and clinical trials.
Bookimed Expert Insight: While transplants at centers like Memorial Şişli Hospital boast a 90% success rate, stem cell therapy is increasingly utilized to manage MELD scores. Data suggests patients often seek these infusions in Istanbul to delay surgery, yet the $12,000 to $21,000 cost is an out-of-pocket expense rarely covered by insurance.
Patient Consensus: Many patients view these treatments as a temporary way to gain energy and manage symptoms. However, those with advanced disease emphasize that it must not delay getting on a formal transplant list as a primary backup plan.
Stem cell treatment for liver cirrhosis in Turkey works by injecting mesenchymal or bone marrow-derived cells to reduce organ scarring and stimulate tissue repair. These cells release anti-inflammatory cytokines, inhibit scar-producing stellate cells, and may differentiate into functional hepatocyte-like cells to improve overall liver filtration and protein production.
Bookimed Expert Insight: Data from leading Istanbul centers like Memorial Şişli Hospital shows that a single session is rarely enough for long-term stability. Most successful outcomes involve 2 to 3 treatment rounds. Patients should verify that their protocol includes oversight from a gastroenterology specialist like Dr. Mete Akin to ensure the treatment aligns with their MELD score requirements.
Patient Consensus: Many report a noticeable reduction in fluid retention and improved energy levels for 6 to 18 months. However, patients emphasize that strict lifestyle changes and low-sodium diets are essential to maintaining these temporary laboratory improvements.
Patients should plan to stay in Turkey for 10 to 21 days for stem cell therapy and recovery. This timeframe includes 4 to 7 days for active treatment and 7 to 14 days for vital post-procedure monitoring to ensure liver stability before air travel.
Bookimed Expert Insight: While general stem cell packages often suggest 7 days, our data shows a 14-to-21-day stay is safer for cirrhosis. Istanbul centers like Memorial Şişli Hospital provide integrated monitoring that helps manage potential ascites flares or liver-enzyme spikes. Extending your stay by just 3 to 5 days specifically for post-infusion blood work can prevent emergency readmissions after returning home.
Patient Consensus: Patients emphasize budgeting for extra rest days, as the regenerative process often causes deep fatigue during the first 10 days. Staying near the clinic for immediate IV fluid access significantly improves the early recovery experience.